Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational Policymclaren health plan Prior Auth Policy Update | Ope…
    Ask Trek AI about this page
    Currentmclaren health planPolicy N/A

    Commercial Medication Exception Review Process

    Customize your policy alerts

    Sign up for all mclaren health plan policy alerts

    Know when mclaren health plan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs McLaren Health Plan's prior authorization (PA) and formulary exception process for commercial medications, describing how members and prescribers request standard and expedited reviews, internal review outcomes, and appeal pathways. Affects MHP commercial members, their prescribing providers, and PBM staff.

    Policy Summary
    Payermclaren health plan
    PolicyCommercial Medication Exception Review Process
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit a completed MedImpact Request for Prior Authorization form and fax supporting documentation to MedImpact (Fax: (858) 790-7100) or call the MedImpact Help Desk to begin the process.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    72 hoursstandard decision timeframe
    24 hoursexpedited decision timeframe
    180 daysinternal appeal filing window
    (858) 790-7100fax to submit requests

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    (888) 274-9689phone to begin PA (24/7)

    Coverage criteria and process

    Coverage criteria and process

    Covered when the following conditions and procedural requirements are met:

    Drugs may be designated non-formulary, non-covered, or prior-authorization (PA) required for reasons including: exclusion from the benefit; found ineffective by the Quality Improvement Committee (QIC); availability of formulary alternatives; or lack of FDA approval.
    Formulary exception requests must include clinical justification that all covered formulary medications on any tier are or have been ineffective, would not be as effective, or would have adverse effects compared to the requested non-formulary medication.

    ALL of the following

    • Submit a completed MedImpact Request for Prior Authorization form with supporting documentation by fax to MedImpact (Fax: (858) 790-7100) or call the MedImpact Help Desk (888-274-9689, TTY 711) to begin the process.
    • For expedited (exigent) review, select the REQUEST FOR EXPEDITED/URGENT REVIEW option on the PA form and fax or call MedImpact to initiate an expedited review.
    • Standard formulary exception determinations: MHP will notify the member (or authorized representative) and the prescriber within 72 hours of receipt of the request.
    • Expedited/exigent determinations: MHP will notify the member (or authorized representative) and the prescriber within 24 hours of receipt of the request.

    ALL of the following

    • Approved: PBM pharmacist contacts MHP CMO/authorized representative; if approved, PBM will enter an authorization (override) into the member's electronic profile for the length of time approved by the health plan (no additional precertification number required at the dispensing pharmacy).
    • Pending: MHP requests additional information; PBM will contact the prescriber for supporting documentation and all Utilization Management timeframes apply.
    • Denied: The CMO or authorized representative denies the request; MHP Utilization Management denial and appeals policies apply and the member has the right to appeal.

    ALL of the following

    • If prior authorization procedures are not followed, the PA request may be withdrawn and the medication may be non-covered; the member may be responsible for full charges.

    ALL of the following

    • If denied, the member may file internal appeals per MHP policy (see appeals procedures); timelines for standard and expedited reviews apply to appeals as well.

    ALL of the following

    • If approved, the PBM will enter the authorization for the length of time approved by MHP into the member's electronic profile.

    Authorization duration and coding notes

    Not specifiedmixed
    No specific billing, CPT, HCPCS, NDC, or ICD-10 codes are listed in this document.
    Authorization duration — inv-03
    Authorization durationAs directed by MHP — the PBM will enter an authorization (override) into the member's electronic profile for the length of time approved by the health plan (entered into member electronic profile).
    Pharmacy dispensingOnce approved and entered into the member electronic profile, dispensing pharmacy does not need a special precertification/prior authorization number.
    Policy sourceDuration determined by McLaren Health Plan clinical determination at time of approval.

    How providers submit requests and what happens next

    Prior Authorization

    Standard prior authorization submission

    Complete the MedImpact Request for Prior Authorization form and submit it with all supporting documentation by fax to MedImpact at (858) 790-7100 or begin the process by calling the MedImpact Help Desk at (888) 274-9689 (TTY 711).

    • Use the MedImpact Standard MRF (Request for Prior Authorization).
    • Fax completed form and supporting documentation to MedImpact: (858) 790-7100.
    • Or call MedImpact Help Desk 24/7 to begin the process: (888) 274-9689 (TTY 711).
    Prior Authorization

    Expedited prior authorization submission

    Indicate urgent need by selecting the REQUEST FOR EXPEDITED/URGENT REVIEW option on the PA form, then fax the completed form and supporting documentation to MedImpact (Fax: (858) 790-7100) or call the MedImpact Help Desk to initiate the expedited review.

    • Select REQUEST FOR EXPEDITED/URGENT REVIEW on the PA form.

    Key definitions

    Prior Authorization (PA) — inv-09
    DefinitionPrior Authorization (PA): a requirement that a medication receive special approval before consideration for coverage under MHP, often due to safety concerns or to ensure a formulary alternative cannot be used.
    When requiredPA is placed on certain formulary medications for safety, effectiveness, or availability of formulary alternatives; a drug may be excluded from benefit, found ineffective by QIC, have formulary alternatives, or lack FDA approval.
    Consequence of no PAIf prior authorization procedures are not followed, the request may be withdrawn and the medication may be non-covered; member may be responsible for full charges.
    Formulary Exception — inv-10
    DefinitionFormulary Exception: a request by a member or prescriber for coverage of a clinically appropriate non-formulary medication requiring justification that formulary options are ineffective, less effective, or cause adverse effects.
    Policy Summary
    Payermclaren health plan
    PolicyCommercial Medication Exception Review Process
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit a completed MedImpact Request for Prior Authorization form and fax supporting documentation to MedImpact (Fax: (858) 790-7100) or call the MedImpact Help Desk to begin the process.
    SourceLink
    On This Page
    Coverage criteria and processAuthorization duration and coding notesHow providers submit requests and what happens nextKey definitions
  1. Fax completed expedited request and documentation to MedImpact: (858) 790-7100.
  2. Or call MedImpact Help Desk (888) 274-9689, TTY 711 to initiate expedited (exigent) review.
  3. Documentation Required

    Internal review steps and communications

    A PBM pharmacist will review the request for content and will contact MHP’s Chief Medical Officer (CMO) or an authorized representative for benefit determination; if more information is needed, the PBM will contact the prescriber.

    • PBM pharmacist reviews the exception/PA request for content.
    • PBM contacts MHP CMO or authorized representative for review and benefit determination.
    • If pending, PBM will contact the prescriber to request additional information.
    Billing Rule

    Approval processing

    If the request is approved, the PBM will enter an authorization (override) into the member’s electronic profile for the length of time approved by MHP; once approved, the dispensing pharmacy will not need a special precertification/prior authorization number.

    • Authorization (override) entered into member electronic profile for approved duration as directed by MHP.
    • Dispensing pharmacy will not require a special PA/precertification number after approval.
    Denial Risk

    Denial risk for not following procedures

    Failure to follow the PA procedures may result in withdrawal of the PA request and the medication being non‑covered; the member may be responsible for full charges.

    • If PA procedures are not followed, the PA request may be withdrawn.
    • Non-coverage may result and the member may be liable for full charges.
    Required justificationRequest must state that all covered formulary medications on any tier are or have been ineffective, would not be as effective, or would have adverse effects.
    Decision timingStandard formulary exception determinations: MHP will notify the member/authorized representative and prescriber within 72 hours of receipt; expedited/exigent determinations: within 24 hours.
    Internal review outcomes — inv-11
    ApprovedAs directed by MHP, the PBM will enter an authorization (override) into the member's electronic profile for the length of time approved by the health plan (authorization entered).
    PendingMHP is pending the request for more information; the PBM will contact the prescriber to request additional information. Utilization Management time frames apply.
    DeniedThe Chief Medical Officer (CMO) or authorized representative has denied the request. Utilization Management denial and appeals policies established by MHP apply; the member has the right to appeal.